Canonical parameters for CLL diagnosis and prognosis are based on lymphocytes count (total white blood cells) and their phenotypic analysis by flow cytometry using standard antibodies, such as anti-CD19, anti-CD20, anti-CD5 and others [100]. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.